Evidence map›Paper›PMID 29267266›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2018

CGG repeat length and AGG interruptions as indicators of fragile X-associated diminished ovarian reserve.

Jovana Lekovich, Limor Man, Kangpu Xu, Chelsea Canon, Debra Lilienthal, Joshua D Stewart, Nigel Pereira, Zev Rosenwaks, Jeannine Gerhardt

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. International journal of molecular sciences · 2025
    Article
  2. Prevalence of theGenes · 2024
    Article
  3. Article
  4. Review
  5. Ovarian Reserve Disorders, Can We Prevent Them? A Review.International journal of molecular sciences · 2022
    Review
  6. Review
  7. Characterization ofFrontiers in genetics · 2021
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Defining the role of FMR1 gene in unexplained recurrent spontaneous abortion.Journal of assisted reproduction and genetics · 2019
    Article
  14. Genetics of human female infertility†.Biology of reproduction · 2019
    Review
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Jovana LekovichThe Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, Weill Cornell Medicine, New York, New York, USA.
Limor ManThe Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, Weill Cornell Medicine, New York, New York, USA.
Kangpu XuThe Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, Weill Cornell Medicine, New York, New York, USA.
Chelsea CanonDepartment of Obstetrics and Gynecology, Weill Cornell Medicine, New York, New York, USA.
Debra LilienthalThe Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, Weill Cornell Medicine, New York, New York, USA.
Joshua D StewartThe Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, Weill Cornell Medicine, New York, New York, USA.
Nigel PereiraThe Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, Weill Cornell Medicine, New York, New York, USA.
Zev RosenwaksThe Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, Weill Cornell Medicine, New York, New York, USA.
Jeannine GerhardtThe Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, Weill Cornell Medicine, New York, New York, USA. jeg2039@med.cornell.edu.
Cornell University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeFragile X premutation (PM) carriers may experience difficulties conceiving a child probably due to fragile X-associated diminished ovarian reserve (FXDOR). We investigated which subgroups of carriers with a PM are at higher risk of FXDOR, and whether the number of AGG interruptions within the repeat sequence further ameliorates the risk.

methodsWe compared markers of ovarian reserve, including anti-Müllerian hormone, antral follicle count, and number of oocytes retrieved between different subgroups of patients with a PM.

resultsWe found that carriers with midrange repeats size (70-90 CGG) demonstrate significantly lower ovarian reserve. Additionally, the number of AGG interruptions directly correlated with parameters of ovarian reserve. Patients with longer uninterrupted CGG repeats post-AGG interruptions had the lowest ovarian reserve.

conclusionThis study connects AGG interruptions and certain CGG repeat length to reduced ovarian reserve in carriers with a PM. A possible explanation for our findings is the proposed gonadotoxicity of the FMR1 transcripts. Reduction of AGG interruptions could increase the likelihood that secondary RNA structures in the FMR1 messenger RNA are formed, which could cause cell dysfunction within the ovaries. These findings may provide women with guidance regarding their fertility potential and accordingly assist with their family planning.

Indexed as

Trinucleotide RepeatsAdultAnti-Mullerian HormoneFemaleFragile X Messenger Ribonucleoprotein 1Fragile X SyndromeGene FrequencyHeterozygoteHumansOocytesOvarian ReservePrimary Ovarian InsufficiencyRNA, MessengerTrinucleotide Repeat ExpansionAnti-Mullerian HormoneFMR1 protein, humanFragile X Messenger Ribonucleoprotein 1RNA, MessengerAGG interruptionsFMR1 RNA toxicityfragile X–associated diminished ovarian reservefragile X permutationgenetic counseling

Identifiers

PMID29267266
OpenAlexW2779279745

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.